Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B

Background: There is no consensus for the best treatment of complex cutaneous leishmaniasis (CL). We aimed to describe a cohort of CL, focusing on liposomal amphotericin B (L-AmB) treatment outcome. Methods: We performed a retrospective study in Vall d’Hebron University Hospital (Barcelona, Spain)....

Full description

Bibliographic Details
Main Authors: Maria Ubals, Pau Bosch-Nicolau, Adrián Sánchez-Montalvá, Fernando Salvador, Gloria Aparicio-Español, Elena Sulleiro, Aroa Silgado, Antoni Soriano-Arandes, Maria Espiau, Berta Ferrer, Diana Pou, Begoña Treviño, Israel Molina, Vicente García-Patos
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pathogens
Subjects:
complex cutaneous leishmaniasis
cutaneous leishmaniasis
liposomal amphotericin B
leishmania
systemic therapy
Online Access:https://www.mdpi.com/2076-0817/10/10/1253

Internet

https://www.mdpi.com/2076-0817/10/10/1253

Similar Items